Zodiac-JRD-MKJ Limited reported a rise in net profit for the quarter ended June 30, 2026. Standalone profit grew to ₹0.41 crore from ₹0.11 crore year-on-year. The company is awaiting regulatory approval for its rights issue.
Zodiac-JRD-MKJ Ltd Reports Q1 FY27 Results and Corporate Actions
Zodiac-JRD-MKJ Limited's standalone net profit increased to ₹0.41 crore for the quarter ended June 30, 2026, up from ₹0.11 crore in the same period last year. Consolidated net profit rose to ₹0.92 crore from ₹0.35 crore year-on-year. Reader Takeaway: Profitability improves; rights issue progress and AGM key for shareholders. ## What just happened Zodiac-JRD-MKJ Limited announced its financial results for the first quarter of the fiscal year 2027, ending June 30, 2026. The company reported an increase in both standalone and consolidated net profits compared to the corresponding quarter in the previous fiscal year. Standalone revenue for the quarter stood at ₹6.23 crore, a rise from ₹4.20 crore in the year-ago period. Standalone net profit grew significantly to ₹0.41 crore from ₹0.11 crore. Consolidated revenue was ₹12.95 crore, a slight increase from ₹12.78 crore. Consolidated net profit improved to ₹0.92 crore from ₹0.35 crore. Additionally, the company's board approved an increase in authorized share capital from ₹18 crore to ₹27 crore. The 39th Annual General Meeting (AGM) is scheduled for September 24, 2026. The company also provided an update on its pending rights issue, stating it is under process and contingent on receiving in-principle approval from BSE Limited. ## Why this matters The reported profit growth suggests an improving operational performance for Zodiac-JRD-MKJ Limited. The increase in authorized capital signals future expansion or fundraising plans. However, the critical factor for investors remains the progress of the rights issue, which is pending regulatory clearance. The upcoming AGM will also be an important event for shareholders. ## The backstory Zodiac-JRD-MKJ Limited has been focused on navigating its corporate actions, including a rights issue, while maintaining its operational performance. The company's financial results have shown fluctuations in the past, making year-on-year comparisons crucial for assessing current trends. ## What changes now Shareholders can expect further updates on the rights issue once the necessary approvals are obtained. The increased authorized capital provides the company with more flexibility for future financial strategies. The company has also re-appointed its statutory auditor, Mr. Girish L. Shethia, for another five-year term. ## Risks to watch The primary risk for investors is the delay or non-receipt of approval for the rights issue from BSE Limited, which could impact the company's planned capital infusion and subsequent growth initiatives. Any further delays or changes in the regulatory landscape could also pose challenges. ## Peer comparison While specific peer performance data for the same quarter is not provided in the filing, the textile and apparel industry in India, where Zodiac-JRD-MKJ operates, is subject to market demand, raw material costs, and competitive pressures. ## Context metrics (time-bound) * **Quarter ended June 30, 2026:** * Standalone Revenue: ₹6.23 crore * Standalone Net Profit: ₹0.41 crore * Consolidated Revenue: ₹12.95 crore * Consolidated Net Profit: ₹0.92 crore * **Quarter ended June 30, 2025:** * Standalone Revenue: ₹4.20 crore * Standalone Net Profit: ₹0.11 crore * Consolidated Revenue: ₹12.78 crore * Consolidated Net Profit: ₹0.35 crore ## What to track next Investors should closely monitor the progress of the rights issue approval from BSE Limited and the company's communication regarding the same. The outcomes of the 39th AGM and any further announcements regarding capital utilization will also be important.
